One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1016/j.annonc.2021.10.086
Copy DOI Journal: Annals of Oncology |  Publication Date: Dec 1, 2021 |
 Citations: 1 |  License type: publisher-specific-oa |
Affiliation: Centre Eugène Marquis, Kanazawa University, California Pacific Medical Center, Eisai (United States), Royal Free London NHS Foundation Trust, Eisai (Japan), Toranomon Hospital, Ronald Reagan UCLA Medical Center, UCLA Medical Center, MSD (United States), Icahn School of Medicine at Mount Sinai, Massachusetts General Hospital, Kindai University, National Cancer Center Hospital East, Tisch Hospital68P A phase Ib study of lenvatinib + pembrolizumab (LEN + PEMBRO) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Study 116 follow-up analysis
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
